PDL-1 positive

Clinical trials for PDL-1 positive explained in plain language.

Never miss a new study

Get alerted when new PDL-1 positive trials appear

Sign up with your email to follow new studies for PDL-1 positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Promising breast cancer combo trial pulled before it even started

Disease control Cancelled

This was a phase II trial testing a combination of three drugs—zimberelimab, domvanalimab, and sacituzumab govitecan—as a first treatment for people with advanced triple-negative breast cancer that is PD-L1 positive. The study aimed to see how well the drugs shrank tumors and how…

Matched conditions: PDL-1 POSITIVE

Phase 2 • Sponsor: MedSIR • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC

PDL-1 positive

Get alerted when new PDL-1 positive trials appear

Promising breast cancer combo trial pulled before it even started